Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 230

1.

Long-term Outcomes and Cost-effectiveness of Breast Cancer Screening with Digital Breast Tomosynthesis in the United States.

Lowry KP, Trentham-Dietz A, Schechter CB, Alagoz O, Barlow WE, Burnside ES, Conant EF, Hampton JM, Huang H, Kerlikowske K, Lee SJ, Miglioretti DL, Sprague BL, Tosteson ANA, Yaffe M, Stout NK.

J Natl Cancer Inst. 2019 Sep 10. pii: djz184. doi: 10.1093/jnci/djz184. [Epub ahead of print]

PMID:
31503283
2.

Environmental exposures during windows of susceptibility for breast cancer: a framework for prevention research.

Terry MB, Michels KB, Brody JG, Byrne C, Chen S, Jerry DJ, Malecki KMC, Martin MB, Miller RL, Neuhausen SL, Silk K, Trentham-Dietz A; Breast Cancer and the Environment Research Program (BCERP).

Breast Cancer Res. 2019 Aug 20;21(1):96. doi: 10.1186/s13058-019-1168-2. Review.

3.

Factors associated with genetic testing in a cohort of breast cancer survivors.

Blaes AH, Jewett PI, McKay K, Riley D, Jatoi I, Trentham-Dietz A, Chrischilles E, Klemp JR.

Breast J. 2019 Jul 3. doi: 10.1111/tbj.13440. [Epub ahead of print]

PMID:
31270889
4.

Age-based versus Risk-based Mammography Screening in Women 40-49 Years Old: A Cross-sectional Study.

Burnside ES, Trentham-Dietz A, Shafer CM, Hampton JM, Alagoz O, Cox JR, Mischo E, Schrager SB, Wilke LG.

Radiology. 2019 Aug;292(2):321-328. doi: 10.1148/radiol.2019181651. Epub 2019 Jun 11.

5.

The association between cancer care coordination and quality of life is stronger for breast cancer patients with lower health literacy: A Greater Plains Collaborative study.

McDowell BD, Klemp J, Blaes A, Cohee AA, Trentham-Dietz A, Kamaraju S, Otte JL, Mott SL, Chrischilles EA.

Support Care Cancer. 2019 Jun 5. doi: 10.1007/s00520-019-04894-y. [Epub ahead of print]

PMID:
31168710
6.

Association of Digital Breast Tomosynthesis vs Digital Mammography With Cancer Detection and Recall Rates by Age and Breast Density.

Conant EF, Barlow WE, Herschorn SD, Weaver DL, Beaber EF, Tosteson ANA, Haas JS, Lowry KP, Stout NK, Trentham-Dietz A, diFlorio-Alexander RM, Li CI, Schnall MD, Onega T, Sprague BL; Population-based Research Optimizing Screening Through Personalized Regimen (PROSPR) Consortium.

JAMA Oncol. 2019 May 1;5(5):635-642. doi: 10.1001/jamaoncol.2018.7078.

PMID:
30816931
7.

Time-varying risks of second events following a DCIS diagnosis in the population-based Vermont DCIS cohort.

Sprague BL, Vacek PM, Herschorn SD, James TA, Geller BM, Trentham-Dietz A, Stein JL, Weaver DL.

Breast Cancer Res Treat. 2019 Feb;174(1):227-235. doi: 10.1007/s10549-018-5048-8. Epub 2018 Nov 17.

PMID:
30448897
8.

Obesity and mortality after locoregional breast cancer diagnosis.

Moore AH, Trentham-Dietz A, Burns M, Gangnon RE, Greenberg CC, Vanness DJ, Hampton J, Wu XC, Anderson RT, Lipscomb J, Kimmick GG, Cress R, Wilson JF, Sabatino SA, Fleming ST.

Breast Cancer Res Treat. 2018 Dec;172(3):647-657. doi: 10.1007/s10549-018-4932-6. Epub 2018 Aug 29.

PMID:
30159788
9.

Variation in coordination of care reported by breast cancer patients according to health literacy.

Mora-Pinzon MC, Chrischilles EA, Greenlee RT, Hoeth L, Hampton JM, Smith MA, McDowell BD, Wilke LG, Trentham-Dietz A.

Support Care Cancer. 2019 Mar;27(3):857-865. doi: 10.1007/s00520-018-4370-3. Epub 2018 Jul 31.

PMID:
30062586
10.

The effect of mammography screening regimen on incidence-based breast cancer mortality.

Yaffe MJ, Mittmann N, Alagoz O, Trentham-Dietz A, Tosteson AN, Stout NK.

J Med Screen. 2018 Dec;25(4):197-204. doi: 10.1177/0969141318780152. Epub 2018 Jul 26.

PMID:
30049249
11.

Introduction to the Cancer Intervention and Surveillance Modeling Network (CISNET) Breast Cancer Models.

Alagoz O, Berry DA, de Koning HJ, Feuer EJ, Lee SJ, Plevritis SK, Schechter CB, Stout NK, Trentham-Dietz A, Mandelblatt JS; CISNET Breast Cancer Working Group members.

Med Decis Making. 2018 Apr;38(1_suppl):3S-8S. doi: 10.1177/0272989X17737507.

12.

The University of Wisconsin Breast Cancer Epidemiology Simulation Model: An Update.

Alagoz O, Ergun MA, Cevik M, Sprague BL, Fryback DG, Gangnon RE, Hampton JM, Stout NK, Trentham-Dietz A.

Med Decis Making. 2018 Apr;38(1_suppl):99S-111S. doi: 10.1177/0272989X17711927.

13.

Comparing CISNET Breast Cancer Incidence and Mortality Predictions to Observed Clinical Trial Results of Mammography Screening from Ages 40 to 49.

van den Broek JJ, van Ravesteyn NT, Mandelblatt JS, Huang H, Ergun MA, Burnside ES, Xu C, Li Y, Alagoz O, Lee SJ, Stout NK, Song J, Trentham-Dietz A, Plevritis SK, Moss SM, de Koning HJ.

Med Decis Making. 2018 Apr;38(1_suppl):140S-150S. doi: 10.1177/0272989X17718168.

14.

Contribution of Breast Cancer to Overall Mortality for US Women.

Gangnon RE, Stout NK, Alagoz O, Hampton JM, Sprague BL, Trentham-Dietz A.

Med Decis Making. 2018 Apr;38(1_suppl):24S-31S. doi: 10.1177/0272989X17717981.

15.

Common Model Inputs Used in CISNET Collaborative Breast Cancer Modeling.

Mandelblatt JS, Near AM, Miglioretti DL, Munoz D, Sprague BL, Trentham-Dietz A, Gangnon R, Kurian AW, Weedon-Fekjaer H, Cronin KA, Plevritis SK.

Med Decis Making. 2018 Apr;38(1_suppl):9S-23S. doi: 10.1177/0272989X17700624.

16.

Urinary Magnesium and Other Elements in Relation to Mammographic Breast Density, a Measure of Breast Cancer Risk.

Mora-Pinzon MC, Trentham-Dietz A, Gangnon RE, Adams SV, Hampton JM, Burnside E, Shafer MM, Newcomb PA.

Nutr Cancer. 2018 Apr;70(3):441-446. doi: 10.1080/01635581.2018.1446094. Epub 2018 Mar 14.

17.

Genetic variation in sensitivity to estrogens and breast cancer risk.

Jerry DJ, Shull JD, Hadsell DL, Rijnkels M, Dunphy KA, Schneider SS, Vandenberg LN, Majhi PD, Byrne C, Trentham-Dietz A.

Mamm Genome. 2018 Feb;29(1-2):24-37. doi: 10.1007/s00335-018-9741-z. Epub 2018 Feb 27. Review.

18.

Cost-effectiveness of mammography from a publicly funded health care system perspective.

Mittmann N, Stout NK, Tosteson ANA, Trentham-Dietz A, Alagoz O, Yaffe MJ.

CMAJ Open. 2018 Feb 8;6(1):E77-E86. doi: 10.9778/cmajo.20170106.

19.

Geographic access to mammography facilities and frequency of mammography screening.

Jewett PI, Gangnon RE, Elkin E, Hampton JM, Jacobs EA, Malecki K, LaGro J, Newcomb PA, Trentham-Dietz A.

Ann Epidemiol. 2018 Feb;28(2):65-71.e2. doi: 10.1016/j.annepidem.2017.11.012. Epub 2017 Dec 7.

20.

Family History and Breast Cancer Risk Among Older Women in the Breast Cancer Surveillance Consortium Cohort.

Braithwaite D, Miglioretti DL, Zhu W, Demb J, Trentham-Dietz A, Sprague B, Tice JA, Onega T, Henderson LM, Buist DSM, Ziv E, Walter LC, Kerlikowske K; Breast Cancer Surveillance Consortium.

JAMA Intern Med. 2018 Apr 1;178(4):494-501. doi: 10.1001/jamainternmed.2017.8642.

21.

The association between post-diagnosis health behaviors and long-term quality of life in survivors of ductal carcinoma in situ: a population-based longitudinal cohort study.

Hart V, Trentham-Dietz A, Berkman A, Fujii M, Veal C, Hampton J, Gangnon RE, Newcomb PA, Gilchrist SC, Sprague BL.

Qual Life Res. 2018 May;27(5):1237-1247. doi: 10.1007/s11136-018-1807-6. Epub 2018 Feb 7.

22.

Rat models of 17β-estradiol-induced mammary cancer reveal novel insights into breast cancer etiology and prevention.

Shull JD, Dennison KL, Chack AC, Trentham-Dietz A.

Physiol Genomics. 2018 Mar 1;50(3):215-234. doi: 10.1152/physiolgenomics.00105.2017. Epub 2018 Jan 26. Review.

23.

Association of Screening and Treatment With Breast Cancer Mortality by Molecular Subtype in US Women, 2000-2012.

Plevritis SK, Munoz D, Kurian AW, Stout NK, Alagoz O, Near AM, Lee SJ, van den Broek JJ, Huang X, Schechter CB, Sprague BL, Song J, de Koning HJ, Trentham-Dietz A, van Ravesteyn NT, Gangnon R, Chandler Y, Li Y, Xu C, Ergun MA, Huang H, Berry DA, Mandelblatt JS.

JAMA. 2018 Jan 9;319(2):154-164. doi: 10.1001/jama.2017.19130. Erratum in: JAMA. 2018 Feb 20;319(7):724.

24.

Distinguishing between CISNET model results versus CISNET models.

Berry DA, de Koning HJ, Lee SJ, Mandelblatt JS, Plevritis SK, Schechter CB, Stout NK, Trentham-Dietz A; CISNET Breast Working Group Principal Investigators.

Cancer. 2018 Mar 1;124(5):1083-1084. doi: 10.1002/cncr.31150. Epub 2017 Dec 26. No abstract available.

25.

Comparative effectiveness of incorporating a hypothetical DCIS prognostic marker into breast cancer screening.

Trentham-Dietz A, Ergun MA, Alagoz O, Stout NK, Gangnon RE, Hampton JM, Dittus K, James TA, Vacek PM, Herschorn SD, Burnside ES, Tosteson ANA, Weaver DL, Sprague BL.

Breast Cancer Res Treat. 2018 Feb;168(1):229-239. doi: 10.1007/s10549-017-4582-0. Epub 2017 Nov 28.

26.

Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study.

Rutter CM, Kim JJ, Meester RGS, Sprague BL, Burger EA, Zauber AG, Ergun MA, Campos NG, Doubeni CA, Trentham-Dietz A, Sy S, Alagoz O, Stout N, Lansdorp-Vogelaar I, Corley DA, Tosteson ANA.

Cancer Epidemiol Biomarkers Prev. 2018 Feb;27(2):158-164. doi: 10.1158/1055-9965.EPI-17-0378. Epub 2017 Nov 17.

27.

Collagen Alignment as a Predictor of Recurrence after Ductal Carcinoma In Situ.

Conklin MW, Gangnon RE, Sprague BL, Van Gemert L, Hampton JM, Eliceiri KW, Bredfeldt JS, Liu Y, Surachaicharn N, Newcomb PA, Friedl A, Keely PJ, Trentham-Dietz A.

Cancer Epidemiol Biomarkers Prev. 2018 Feb;27(2):138-145. doi: 10.1158/1055-9965.EPI-17-0720. Epub 2017 Nov 15.

28.

Emerging Trends in Family History of Breast Cancer and Associated Risk.

Shiyanbola OO, Arao RF, Miglioretti DL, Sprague BL, Hampton JM, Stout NK, Kerlikowske K, Braithwaite D, Buist DSM, Egan KM, Newcomb PA, Trentham-Dietz A.

Cancer Epidemiol Biomarkers Prev. 2017 Dec;26(12):1753-1760. doi: 10.1158/1055-9965.EPI-17-0531. Epub 2017 Oct 6.

29.

Racial and Socioeconomic Disparities Are More Pronounced in Inflammatory Breast Cancer Than Other Breast Cancers.

Denu RA, Hampton JM, Currey A, Anderson RT, Cress RD, Fleming ST, Lipscomb J, Wu XC, Wilson JF, Trentham-Dietz A.

J Cancer Epidemiol. 2017;2017:7574946. doi: 10.1155/2017/7574946. Epub 2017 Aug 15.

30.

Mammography Screening: Gaps in Patient's and Physician's Needs for Shared Decision-Making.

DuBenske LL, Schrager S, McDowell H, Wilke LG, Trentham-Dietz A, Burnside ES.

Breast J. 2017 Mar;23(2):210-214. doi: 10.1111/tbj.12779. Epub 2017 Mar 2.

31.

Health-related behaviors and mortality outcomes in women diagnosed with ductal carcinoma in situ.

Veal CT, Hart V, Lakoski SG, Hampton JM, Gangnon RE, Newcomb PA, Higgins ST, Trentham-Dietz A, Sprague BL.

J Cancer Surviv. 2017 Jun;11(3):320-328. doi: 10.1007/s11764-016-0590-z. Epub 2017 Jan 5.

32.

Urinary Cadmium and Mammographic Density.

Adams SV, Hampton JM, Trentham-Dietz A, Gangnon RE, Shafer MM, Newcomb PA.

Epidemiology. 2017 Jan;28(1):e6-e7. No abstract available.

PMID:
27902535
33.

Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes.

Trentham-Dietz A, Kerlikowske K, Stout NK, Miglioretti DL, Schechter CB, Ergun MA, van den Broek JJ, Alagoz O, Sprague BL, van Ravesteyn NT, Near AM, Gangnon RE, Hampton JM, Chandler Y, de Koning HJ, Mandelblatt JS, Tosteson AN; Breast Cancer Surveillance Consortium and the Cancer Intervention and Surveillance Modeling Network.

Ann Intern Med. 2016 Nov 15;165(10):700-712. doi: 10.7326/M16-0476. Epub 2016 Aug 23.

34.

Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers.

Schmidt MK, Hogervorst F, van Hien R, Cornelissen S, Broeks A, Adank MA, Meijers H, Waisfisz Q, Hollestelle A, Schutte M, van den Ouweland A, Hooning M, Andrulis IL, Anton-Culver H, Antonenkova NN, Antoniou AC, Arndt V, Bermisheva M, Bogdanova NV, Bolla MK, Brauch H, Brenner H, Brüning T, Burwinkel B, Chang-Claude J, Chenevix-Trench G, Couch FJ, Cox A, Cross SS, Czene K, Dunning AM, Fasching PA, Figueroa J, Fletcher O, Flyger H, Galle E, García-Closas M, Giles GG, Haeberle L, Hall P, Hillemanns P, Hopper JL, Jakubowska A, John EM, Jones M, Khusnutdinova E, Knight JA, Kosma VM, Kristensen V, Lee A, Lindblom A, Lubinski J, Mannermaa A, Margolin S, Meindl A, Milne RL, Muranen TA, Newcomb PA, Offit K, Park-Simon TW, Peto J, Pharoah PD, Robson M, Rudolph A, Sawyer EJ, Schmutzler RK, Seynaeve C, Soens J, Southey MC, Spurdle AB, Surowy H, Swerdlow A, Tollenaar RA, Tomlinson I, Trentham-Dietz A, Vachon C, Wang Q, Whittemore AS, Ziogas A, van der Kolk L, Nevanlinna H, Dörk T, Bojesen S, Easton DF.

J Clin Oncol. 2016 Aug 10;34(23):2750-60. doi: 10.1200/JCO.2016.66.5844. Epub 2016 Jun 6.

35.

Emerging trends in surgical and adjuvant radiation therapies among women diagnosed with ductal carcinoma in situ.

Shiyanbola OO, Sprague BL, Hampton JM, Dittus K, James TA, Herschorn S, Gangnon RE, Weaver DL, Trentham-Dietz A.

Cancer. 2016 Sep 15;122(18):2810-8. doi: 10.1002/cncr.30105. Epub 2016 May 31.

36.

The Role of Intraoperative Pathologic Assessment in the Surgical Management of Ductal Carcinoma In Situ.

Decker MR, Trentham-Dietz A, Loconte NK, Neuman HB, Smith MA, Punglia RS, Greenberg CC, Wilke LG.

Ann Surg Oncol. 2016 Sep;23(9):2788-94. doi: 10.1245/s10434-016-5192-5. Epub 2016 Mar 29.

37.

Trends in Health-Related Quality of Life After a Diagnosis of Ductal Carcinoma In Situ.

Hart V, Sprague BL, Lakoski SG, Hampton JM, Newcomb PA, Gangnon RE, Trentham-Dietz A.

J Clin Oncol. 2016 Apr 20;34(12):1323-9. doi: 10.1200/JCO.2015.62.7281. Epub 2016 Feb 16. Erratum in: J Clin Oncol. 2016 Aug 20;34(24):2943.

38.

What Predicts an Advanced-Stage Diagnosis of Breast Cancer? Sorting Out the Influence of Method of Detection, Access to Care, and Biologic Factors.

Lipscomb J, Fleming ST, Trentham-Dietz A, Kimmick G, Wu XC, Morris CR, Zhang K, Smith RA, Anderson RT, Sabatino SA; Centers for Disease Control and Prevention National Program of Cancer Registries Patterns of Care Study Group.

Cancer Epidemiol Biomarkers Prev. 2016 Apr;25(4):613-23. doi: 10.1158/1055-9965.EPI-15-0225. Epub 2016 Jan 27.

39.

Cigarette Smoking Before and After Breast Cancer Diagnosis: Mortality From Breast Cancer and Smoking-Related Diseases.

Passarelli MN, Newcomb PA, Hampton JM, Trentham-Dietz A, Titus LJ, Egan KM, Baron JA, Willett WC.

J Clin Oncol. 2016 Apr 20;34(12):1315-22. doi: 10.1200/JCO.2015.63.9328. Epub 2016 Jan 25.

40.

Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies.

Mandelblatt JS, Stout NK, Schechter CB, van den Broek JJ, Miglioretti DL, Krapcho M, Trentham-Dietz A, Munoz D, Lee SJ, Berry DA, van Ravesteyn NT, Alagoz O, Kerlikowske K, Tosteson AN, Near AM, Hoeffken A, Chang Y, Heijnsdijk EA, Chisholm G, Huang X, Huang H, Ergun MA, Gangnon R, Sprague BL, Plevritis S, Feuer E, de Koning HJ, Cronin KA.

Ann Intern Med. 2016 Feb 16;164(4):215-25. doi: 10.7326/M15-1536. Epub 2016 Jan 12.

41.

Total cost-effectiveness of mammography screening strategies.

Mittmann N, Stout NK, Lee P, Tosteson AN, Trentham-Dietz A, Alagoz O, Yaffe MJ.

Health Rep. 2015 Dec;26(12):16-25.

42.

Clinical outcomes of modelling mammography screening strategies.

Yaffe MJ, Mittmann N, Lee P, Tosteson AN, Trentham-Dietz A, Alagoz O, Stout NK.

Health Rep. 2015 Dec;26(12):9-15.

43.

Modelling mammography screening for breast cancer in the Canadian context: Modification and testing of a microsimulation model.

Yaffe MJ, Mittmann N, Lee P, Tosteson AN, Trentham-Dietz A, Alagoz O, Stout NK.

Health Rep. 2015 Dec;26(12):3-8.

44.

Variation in Screening Abnormality Rates and Follow-Up of Breast, Cervical and Colorectal Cancer Screening within the PROSPR Consortium.

Tosteson AN, Beaber EF, Tiro J, Kim J, McCarthy AM, Quinn VP, Doria-Rose VP, Wheeler CM, Barlow WE, Bronson M, Garcia M, Corley DA, Haas JS, Halm EA, Kamineni A, Rutter CM, Tosteson TD, Trentham-Dietz A, Weaver DL; PROSPR consortium.

J Gen Intern Med. 2016 Apr;31(4):372-9. doi: 10.1007/s11606-015-3552-7.

45.

Influence of patient, physician, and hospital characteristics on the receipt of guideline-concordant care for inflammatory breast cancer.

Denu RA, Hampton JM, Currey A, Anderson RT, Cress RD, Fleming ST, Lipscomb J, Sabatino SA, Wu XC, Wilson JF, Trentham-Dietz A.

Cancer Epidemiol. 2016 Feb;40:7-14. doi: 10.1016/j.canep.2015.11.003. Epub 2015 Nov 21.

46.

Partnership Status and Socioeconomic Factors in Relation to Health Behavior Changes after a Diagnosis of Ductal Carcinoma In Situ.

Khadanga S, Lakoski SG, Hart V, Sprague BL, Ba Y, Hampton JM, Higgins ST, Ades PA, Newcomb PA, Trentham-Dietz A.

Cancer Epidemiol Biomarkers Prev. 2016 Jan;25(1):76-82. doi: 10.1158/1055-9965.EPI-15-0726. Epub 2015 Nov 6.

47.

Cancer Models and Real-world Data: Better Together.

Kim JJ, Tosteson AN, Zauber AG, Sprague BL, Stout NK, Alagoz O, Trentham-Dietz A, Armstrong K, Pruitt SL, Rutter CM; Population-based Research Optimizing Screening through Personalized Regimens (PROSPR) consortium.

J Natl Cancer Inst. 2015 Nov 3;108(2). pii: djv316. doi: 10.1093/jnci/djv316. Print 2016 Feb.

48.

Comparing Mammography Abnormality Features to Genetic Variants in the Prediction of Breast Cancer in Women Recommended for Breast Biopsy.

Burnside ES, Liu J, Wu Y, Onitilo AA, McCarty CA, Page CD, Peissig PL, Trentham-Dietz A, Kitchner T, Fan J, Yuan M.

Acad Radiol. 2016 Jan;23(1):62-9. doi: 10.1016/j.acra.2015.09.007. Epub 2015 Oct 26.

49.

Using Active Learning for Speeding up Calibration in Simulation Models.

Cevik M, Ergun MA, Stout NK, Trentham-Dietz A, Craven M, Alagoz O.

Med Decis Making. 2016 Jul;36(5):581-93. doi: 10.1177/0272989X15611359. Epub 2015 Oct 15.

50.

Health Literacy and Health-Related Quality of Life Among a Population-Based Sample of Cancer Patients.

Halverson JL, Martinez-Donate AP, Palta M, Leal T, Lubner S, Walsh MC, Schaaf Strickland J, Smith PD, Trentham-Dietz A.

J Health Commun. 2015;20(11):1320-9. doi: 10.1080/10810730.2015.1018638. Epub 2015 Jul 10.

Supplemental Content

Loading ...
Support Center